ストックスクリーナーアプリを入手
29.04
6.35%
-1.97
前日終値:
$31.01
開ける：
$30.22
24時間の取引高:
5.75M
Relative Volume:
2.46
時価総額：
$4.79B
収益：
$1.51B
当期純損益:
$333.35M
株価収益率:
14.89
EPS:
1.95
ネットキャッシュフロー:
$315.22M
1週間 パフォーマンス:
-11.71%
1か月 パフォーマンス:
-9.08%
6か月 パフォーマンス:
-5.16%
1年 パフォーマンス:
+2.43%
1日の値動き範囲:
$28.67
$30.36
1週間の範囲:
$27.49
$34.45
52週間の値動き範囲:
$25.16
$36.45
Alkermes Plc Stock (ALKS) Company Profile
ALKS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ALKS
Alkermes Plc
|
29.04 | 5.12B | 1.51B | 333.35M | 315.22M | 1.95 |
|
ZTS
Zoetis Inc
|
120.82 | 53.39B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.29 | 44.99B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.59 | 44.08B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
25.41 | 29.30B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
466.40 | 19.91B | 3.08B | 1.24B | 1.07B | 25.61 |
Alkermes Plc Stock (ALKS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-11 | 開始されました | Truist | Buy |
| 2025-09-26 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-09-03 | 開始されました | Wells Fargo | Overweight |
| 2025-07-15 | 開始されました | Goldman | Buy |
| 2025-06-17 | アップグレード | UBS | Neutral → Buy |
| 2025-05-28 | 開始されました | Needham | Buy |
| 2025-03-13 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2025-03-04 | アップグレード | UBS | Sell → Neutral |
| 2025-02-11 | 開始されました | Deutsche Bank | Buy |
| 2024-11-05 | アップグレード | Stifel | Hold → Buy |
| 2024-06-17 | 開始されました | TD Cowen | Buy |
| 2024-03-19 | 開始されました | Robert W. Baird | Outperform |
| 2024-02-20 | ダウングレード | UBS | Neutral → Sell |
| 2023-11-20 | 再開されました | JP Morgan | Neutral |
| 2023-10-24 | アップグレード | Evercore ISI | In-line → Outperform |
| 2023-10-17 | 開始されました | UBS | Neutral |
| 2022-11-03 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-10-14 | アップグレード | BofA Securities | Underperform → Neutral |
| 2022-08-16 | 開始されました | Piper Sandler | Neutral |
| 2022-04-22 | 再開されました | Goldman | Buy |
| 2022-04-20 | 開始されました | Goldman | Buy |
| 2022-01-27 | アップグレード | Cantor Fitzgerald | Hold → Overweight |
| 2021-12-01 | 開始されました | Citigroup | Neutral |
| 2021-10-07 | アップグレード | Jefferies | Hold → Buy |
| 2021-09-02 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2020-10-15 | アップグレード | Mizuho | Neutral → Buy |
| 2020-07-30 | ダウングレード | Goldman | Neutral → Sell |
| 2020-02-14 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2020-02-14 | 繰り返されました | H.C. Wainwright | Neutral |
| 2020-02-14 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-02-06 | 開始されました | Mizuho | Neutral |
| 2020-01-31 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2019-09-05 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2019-07-15 | アップグレード | Goldman | Sell → Neutral |
| 2019-05-31 | 開始されました | H.C. Wainwright | Neutral |
| 2019-05-01 | ダウングレード | Citigroup | Buy → Neutral |
| 2018-12-19 | ダウングレード | Goldman | Neutral → Sell |
| 2018-12-14 | 開始されました | Wolfe Research | Underperform |
| 2018-12-13 | ダウングレード | Credit Suisse | Outperform → Underperform |
| 2018-11-05 | 開始されました | Piper Jaffray | Neutral |
| 2018-08-07 | 開始されました | Stifel | Hold |
| 2018-06-21 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2018-06-06 | 開始されました | B. Riley FBR, Inc. | Buy |
| 2018-05-16 | アップグレード | Citigroup | Neutral → Buy |
| 2018-05-11 | 開始されました | BofA/Merrill | Buy |
すべてを表示
Alkermes Plc (ALKS) 最新ニュース
How strong is Alkermes plc (8AK) stock earnings growthBull Run & Risk Controlled Swing Trade Alerts - newser.com
Applying Elliott Wave Theory to Alkermes plcQuarterly Market Review & Long-Term Growth Portfolio Plans - newser.com
What moving averages say about Alkermes plc2025 Top Gainers & Technical Confirmation Trade Alerts - newser.com
How Alkermes plc (8AK) stock valuation compares with sectorTrade Analysis Report & Weekly High Return Stock Forecasts - newser.com
What data driven models say about Alkermes plc’s futureNew Guidance & Low Risk Growth Stock Ideas - newser.com
Trading Systems Reacting to (ALKS) Volatility - news.stocktradersdaily.com
Avadel (AVDL) Soars to 10-Year High on Brewing Bidding War - Finviz
Risk vs reward if holding onto Alkermes plcIPO Watch & Risk Managed Investment Strategies - newser.com
How high can Alkermes plc stock goTrade Ideas & Daily Stock Momentum Reports - newser.com
Comparing Alkermes plc in custom built stock radarsOptions Play & AI Powered Market Entry Strategies - newser.com
Will Alkermes plc stock rally after Fed decisionsShare Buyback & Growth Focused Stock Reports - newser.com
Avadel Gets Acquisition Proposal From Lundbeck Weeks After Inking Agreement With Alkermes - MSN
STATE STREET CORP's Strategic Acquisition of Alkermes PLC Shares - GuruFocus
Alkermes responds to potential rival bid for Avadel from Lundbeck By Investing.com - Investing.com Nigeria
Another Bidding War As Lundbeck Swoops In On Alkermes/Avadel Deal - Citeline News & Insights
To Wall Street, a new bidding war puts Alkermes in a tough spot - BioPharma Dive
Avadel Pharmaceuticals Attracts Rival Bids In Buyout Showdown - Finimize
Avadel Faces Competing Bids From Lundbeck And Alkermes - Finimize
Alkermes (ALKS) Positioned for Strategic Acquisition - GuruFocus
Alkermes (ALKS) Shares Decline Amid Market Activity - GuruFocus
Is Alkermes plc forming a bottoming base2025 Support & Resistance & Low Risk Entry Point Guides - newser.com
Lundbeck's Higher Buyout Proposal Challenges Alkermes' Pending $2 Billion Avadel Deal - Benzinga
Is Alkermes plc stock ready for breakoutJuly 2025 Drop Watch & Low Risk Profit Maximizing Plans - Fundação Cultural do Pará
Alkermes (ALKS) Stock Experiences Notable Decline - GuruFocus
Avadel Pharmaceuticals Receives Unsolicited Acquisition Proposal From Lundbeck - MarketScreener
GILD's Investigational Regimen for HIV Treatment Meets Primary Goal - Finviz
Avadel Considers Lundbeck's Proposal Amid Alkermes Agreement (AL - GuruFocus
Alkermes (ALKS) Evaluates Options Following Avadel Pharmaceutica - GuruFocus
Alkermes Response to Avadel Announcement - The AI Journal
Alkermes weighs options after Lundbeck's higher bid for Avadel - MarketScreener
Alkermes responds to competing offer for Avadel from Lundbeck - StreetInsider
Alkermes (NASDAQ: ALKS) notes Avadel must give 5 Business Days’ notice, negotiate - Stock Titan
Is Alkermes plc (8AK) stock considered safe havenJuly 2025 Analyst Calls & Long Hold Capital Preservation Plans - Fundação Cultural do Pará
Avadel climbs as Lundbeck outbids Alkermes in latest bidding war - Seeking Alpha
Lundbeck sparks bidding war with Alkermes; Pfizer closes Metsera deal - Yahoo Finance
Wells Fargo Lowers Price Target for Alkermes (ALKS) to $37 | ALKS Stock News - GuruFocus
Is Alkermes plc (8AK) stock at risk of policy regulationTrend Reversal & Expert Verified Stock Movement Alerts - newser.com
Alkermes at Stifel 2025: Strategic Insights on Narcolepsy Drug - Investing.com
Alkermes Shares Phase 2 Results of Orexin 2 Receptor Agonist in Narcolepsy Type 2 - Sleep Review
Is Alkermes plc a good long term investmentVolatility Trading Techniques & Register for the Next Free Workshop - earlytimes.in
Alkermes Plc (ALKS) 財務データ
収益
当期純利益
現金流量
EPS
2.58%
4.09%
大文字化:
|
ボリューム (24 時間):